(2022) Annual Report, Iowa Prescription Monitoring Program, February 2022. Public Health, Department of (Health and Human Services, Department of)
|
PDF
pmp_report_idph_template_-_format_2021_final_v2.1_0.pdf File Size:2MB |
Abstract
The Iowa Prescription Monitoring Program (PMP) became fully operational on March 25, 2009 and provides authorized prescribers and pharmacists with on-going information regarding their patients’ use of controlled substances, and is used as a tool in determining appropriate prescribing and treatment of patients without fear of contributing to a patient’s abuse of, or dependence on, addictive drugs or diversion of those drugs to illicit use. Iowa licensed pharmacies, both resident and nonresident, and dispensing prescribers, are required to report to the PMP all Schedule II, III, IV and V controlled substances along with opioid antagonists (e.g., naloxone) dispensed to ambulatory patients.
| Item Type: | Departmental Report |
|---|---|
| Keywords: | Drugs, Iowa, Prescription Drugs, Prescription Monitoring, controlled substances |
| Subjects: | Public Safety and consumer protection Public Safety and consumer protection > Public safety Health and medicine > Drugs and pharmacology |
| ID Code: | 43006 |
| Deposited By: | Margaret Barr |
| Deposited On: | 16 Feb 2023 15:50 |
| Last Modified: | 16 Feb 2023 15:50 |
| URI: | https://publications.iowa.gov/id/eprint/43006 |